Viropro Inc.
OTC: VPRO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Michelle Leanne Edythe Peake
- Headquarters
- San Jose, United States
- IPO year
- 1995
- Market cap
- $25.4K
- Website
- https://www.viropro.net
Loading VPRO…
Loading profile data…Frequently asked questions about VPRO
What does Viropro Inc. (VPRO) do?
Viropro Inc., a subsidiary of Alpha Biologics Limited, functions as a contract research and manufacturing organization (CRMO), primarily engaged in the development and production of biotherapeutic proteins aimed at treating diverse medical conditions. The company additionally facilitates the industrial-scale manufacturing of biogeneric therapeut...
Where does VPRO trade?
Viropro Inc. (VPRO) trades on the Other OTC.
What sector is VPRO in?
Viropro Inc. (VPRO) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Viropro Inc.?
Michelle Leanne Edythe Peake is the chief executive officer of Viropro Inc. (VPRO).
Where is Viropro Inc. headquartered?
Viropro Inc. is headquartered in United States.
Does VPRO pay a dividend?
Viropro Inc. (VPRO) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did VPRO go public?
Viropro Inc. (VPRO) completed its initial public offering in 1995.